LATEST ALERTS
Participants at the Paris 420 Festival, organised by NORML France (National Organisation for the Reform of Marijuana Laws), were keen to raise public awareness of hemp’s various properties
A major brand in e-liquids has announced its entry into the CBD sector following its acquisition by a drinks company with CBD interests
Canadian medical cannabis company Canopy Growth has paid €225.9m in cash for C3, a German producer of pharmaceutical grade cannabinoids
A major sports supplement chain is the latest business to bring CBD to its shelves in the US
CBD-Intel News in Brief from the US, Canada and UK
One of the largest CBD companies in the US has opened up a UK base in Northern Ireland, and is on the brink of setting up another in London
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
CBD-Intel News in Brief from the UK, US and Germany
Social media influencers are the marketing medium of the moment, and the CBD market is especially well suited to cashing in on the fame and popularity of this new form of advertising
As a potential CBD and cannabis market emerges in Peru, players from across the globe are seeing a valuable opportunity for investing in the country
CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude
Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits
Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals
An e-cig company that has recently entered the CBD arena has reported record increases in sales and profit
A new hemp extraction facility, said to be the largest in Europe, has opened in the Sicilian province of Ragusa for the production of CBD-containing products such as oils, cosmetics, and pharmaceuticals
An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD companies
A series of year-end results from cannabis-related companies in the US demonstrates the importance of CBD to the bottom line, with volatility in much of the rest of the cannabis and pharmaceutical sectors
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley
David Klein, the man who created the iconic Jelly Belly jelly bean in the 1970s, has entered the CBD edibles market with his latest start-up Spectrum Confections, established to make CBD jelly beans
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders
North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners and medicines from sugars using a yeast-based process, and it is thought it will do the same with CBD. While the company » Continue Reading.
Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market
Ohio-based CBD and cannabis company Green Growth Brands (GGB) is to open 108 retail locations in shopping malls across the US this year, including some of the most high-profile shopping locations in the country
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Interest in the Greek CBD market continues to grow despite an uncertain regulatory situation, with a number of apparent cases of police taking action against people acting entirely legally
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Hemp plants in Italy used for the production of CBD are being grown in buildings heated with biofuel
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
A series of advertisements for CBD products will be seen at Sunday’s Super Bowl LIII between the New England Patriots and the LA Rams, powerfully demonstrating their arrival in the US mainstream
Two CBD products have received kosher status from the largest agency in Europe dealing with rabbinically-approved foodstuffs.
London-based Advance Biotech received kosher certification from KLBD Kosher Certification in September 2018, followed by Provocan, a CBD brand made by Jerusalem-based company Ciitech, later in the year.
Because CBD oils are ingested orally, they require kosher certification.
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.
A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies and says its new products will deliver CBD to a user’s system four times faster than others
A British biopharmaceutical company will be trialling the use of CBD and other hemp-based products for treating opioid addiction, as well as other conditions
The co-founder of an online CBD shop has accused rivals of deceptive marketing. Johan Obel of TheDrug.Store also called for more clarity – and tighter controls – over what is and is not legal in the UK
CBD-Intel’s survey of the Dutch CBD online sales channel looks at one of Europe’s more mature markets. It reveals which products dominate sales and how websites vary their offer
which types of shop are selling which types of CBD products, and the most widely available brands on offer Dutch CBD online market seems more mature in terms of brands and products than other European CBD markets such as the German, Spanish or French.Online sales of CBD products mainly happen through CBD specialised websites and online head shops.
The online market is dominated by CBD oils. CBD flowers are not widely available online.
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Companies which make beverages containing CBD are resorting to new technologies to get around a thorny problem.
CBD is not water soluble, meaning a fatty emulsion needs to be created in order to get the substance to mix with a liquid – but canny companies are using a process called nanemulsion, where the molecule sizes are reduced to enable the CBD to mix better with the drink.
A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country began regulating medical marijuana
Turning Point Brands, one of America’s largest smokeless tobacco and vapour companies, has taken a minority stake in Canadian American Standard Hemp, a company dedicated to CBD products
US tobacco giant Altria has bought a 45% stake in Canadian cannabis company the Cronos Group, with the option to take a majority 55% stake within the next four years
The merger of two companies in the US CBD sector – Level Brands and Cure Based Developments – is dependent on the US Farm Bill legalising CBD at federal level
Charlotte’s Web Holdings, which claims to be the market leader in “innovative hemp-based, CBD wellness products”, says it expects to add national drugstores to its thousands of locations in the US soon
CBD-Intel conducted a survey of health food shops known to sell CBD in seven of the largest cities in the UK in order to understand the product and brand landscape
Among a wave of drinkable CBD products released in the UK this year, one of the more controversial is Love Hemp’s CBD-infused bottled water – advertised as being spring water “infused with CBD hemp droplets”
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
